The new medical technologies and the organizations of medical science and treatment.
作者信息
Fennell Mary L
出版信息
Health Serv Res. 2008 Feb;43(1 Pt 1):1-9. doi: 10.1111/j.1475-6773.2008.00832.x.
Abstract
摘要
相似文献
1
The new medical technologies and the organizations of medical science and treatment.新的医疗技术以及医学科学与治疗的组织架构。
Health Serv Res. 2008 Feb;43(1 Pt 1):1-9. doi: 10.1111/j.1475-6773.2008.00832.x.
2
Building a Culture of Health Informatics Innovation and Entrepreneurship: A New Frontier.构建健康信息学创新与创业文化：一个新领域。
Stud Health Technol Inform. 2015;213:237-40.
3
Innovation in healthcare intelligence: cross-sector convergence beyond electronic medical records.医疗保健智能领域的创新：超越电子病历的跨部门融合。
Am J Prev Med. 2011 May;40(5 Suppl 2):S234-7. doi: 10.1016/j.amepre.2011.02.002.
4
10-year outline unveiled to roll out health information technology.推出卫生信息技术的十年规划公布
Qual Lett Healthc Lead. 2004 Sep;16(9):9-10, 1.
5
The power of information: from policy to implementation.
Community Pract. 2013 Sep;86(9):12, 14.
6
A case study of evaluating informatics impact on diffusion of scientific knowledge.
AMIA Annu Symp Proc. 2008 Nov 6:997.
7
Realigning HIM to the new healthcare environment.
J AHIMA. 2014 Aug;85(8):34-8.
8
Review of information technologies for health care.医疗保健信息技术综述。
Top Health Inf Manage. 1993 Feb;13(3):69-76.
9
The complicated landscape of health IT innovation and its bright future ahead.健康信息技术创新的复杂局面及其光明的未来。
Caring. 2013 Oct;32(8):36-41.
10
The future of health information technology: implications for research.健康信息技术的未来：对研究的启示。
Med Care. 2013 Mar;51(3 Suppl 1):S1-3. doi: 10.1097/MLR.0b013e3182848a52.
引用本文的文献
1
Health services research and data linkages: issues, methods, and directions for the future.卫生服务研究与数据关联：问题、方法与未来方向。
Health Serv Res. 2010 Oct;45(5 Pt 2):1468-88. doi: 10.1111/j.1475-6773.2010.01142.x. Epub 2010 Aug 2.
2
Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program.提高社区环境中的临床研究和癌症护理服务水平：评估 NCI 社区癌症中心计划。
Implement Sci. 2009 Sep 26;4:63. doi: 10.1186/1748-5908-4-63.
本文引用的文献
1
Growth and innovation in medical devices: a conversation with Stryker chairman John Brown. Interview by Lawton R. Burns.医疗设备的增长与创新：与史赛克董事长约翰·布朗的对话。劳顿·R·伯恩斯采访。
Health Aff (Millwood). 2007 May-Jun;26(3):w436-44. doi: 10.1377/hlthaff.26.3.w436. Epub 2007 May 1.
2
Transformative technology: a conversation with E. James Potchen and Bill Clarke. Interview by John K. Inglehart.变革性技术：与E. 詹姆斯·波申和比尔·克拉克的对话。约翰·K. 英格尔哈特访谈
Health Aff (Millwood). 2007 Mar-Apr;26(2):w227-35. doi: 10.1377/hlthaff.26.2.w227. Epub 2007 Feb 13.
3
Getting to 'smart' health care.迈向“智能”医疗保健。
Health Aff (Millwood). 2006 Nov-Dec;25(6):w589-92. doi: 10.1377/hlthaff.25.w589. Epub 2006 Nov 7.
4
Coverage options for promising technologies: Medicare's 'coverage with evidence development'.有前景技术的覆盖选项：医疗保险的“基于证据发展的覆盖”。
Health Aff (Millwood). 2006 Sep-Oct;25(5):1218-30. doi: 10.1377/hlthaff.25.5.1218.
5
Dealing with innovation and costs in orthopedics: a conversation with Dane Miller. Interview by Lawton R Burns.
Health Aff (Millwood). 2006 Jul-Aug;25(4):W241-51. doi: 10.1377/hlthaff.25.w241. Epub 2006 May 18.
6
Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial.将临床试验作为承保条件：来自国家肺气肿治疗试验的经验教训。
Clin Trials. 2004 Feb;1(1):108-14; discussion 115-21. doi: 10.1191/1740774504cn009xx.
7
Standards for gene therapy clinical trials based on pro-active risk assessment in a London NHS Teaching Hospital Trust.基于伦敦一家国民保健服务教学医院信托机构主动风险评估的基因治疗临床试验标准。
QJM. 2005 Feb;98(2):75-86. doi: 10.1093/qjmed/hci013. Epub 2005 Jan 17.
8
Risks in new drug development: approval success rates for investigational drugs.新药研发中的风险：研究性药物的获批成功率
Clin Pharmacol Ther. 2001 May;69(5):297-307. doi: 10.1067/mcp.2001.115446.
Zotero 插件